Display Settings:

Format

Send to:

Choose Destination
    Mol Genet Metab. 2010 May;100(1):20-3. Epub 2010 Jan 4.

    Cognitive and neuroradiological improvement in three patients with attenuated MPS I treated by laronidase.

    Source

    Reference Center for Inherited Metabolic Disorders, Assistance Publique-Hôpitaux de Paris, Necker-Enfants Malades Hospital, University Paris Descartes, Paris, France. vassili.valaya@nck.aphp.fr

    Abstract

    Stem cell transplantation is not appropriate first-line treatment for attenuated phenotypes of mucopolysaccharidosis type I (MPS I). In three patients with attenuated MPSA I treated by laronidase, Patients 2 and 3 displayed significant cognitive improvement within 2years; Patients 1 and 3 displayed improvement on MRI scans of the brain.

    (c) 2010. Published by Elsevier Inc.

    PMID:
    20106688
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk